Novo Nordisk

Healthcare

GLP-1 Race Heats Up with Positive Test Results for Next-Gen Eli Lilly Drug

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Approximately one in eight Americans are taking medications like Ozempic or Wegovy for weight loss, diabetes, heart disease and more.

2 min read

Photo via Michael Siluk/UCG/Universal Images Group/Newscom

Healthcare

Hims Teams up with Novo to Compete for Weight Loss Scripts

The two struck a deal Monday for Hims to offer official versions of Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy.

2 min read
Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Healthcare

Eli Lilly Widens Access to Weight-Loss Injectable as Lower-Cost Pill Nears Approval

Just 20% of firms with 200 or more workers said they covered GLP-1 drugs for weight loss, according to the Peterson-KFF Health System Tracker.

2 min read
Photo via Ritzau Scanpix/Sipa USA/Newscom

Healthcare

Novo Nordisk Launches Suit to Knock Out Hims & Hers’ Weight Loss Knockoffs

Novo’s Copenhagen-listed shares rose 5.2% on Monday. New York-listed shares in Hims & Hers, meanwhile, shed an Ozempic-like 16% in volume.

2 min read

Healthcare

Treatment Advances Position Lilly as Weight-Loss Heavyweight

Photo by JHVEPhoto via iStock

The proliferation of cheaper generic drugs and more competition has already begun to bring down prices on weight-loss treatments.

2 min read

Healthcare

Eli Lilly’s Sterling Results Highlight Rival Novo Nordisk’s Fading Fortunes

Photo by Douglas Cliff via iStock

Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.

2 min read

Healthcare

Eli Lilly Captures Major Lead in Weight-Loss Pill Race

Photo by jetcityimage via iStock

Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

2 min read

Photo via Marcus Brandt/dpa/picture-alliance/Newscom

Healthcare

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official website.

2 min read
Photo via Spencer Jones/GHI//UCG/Universal Images Group/Newscom

Healthcare

Eli Lilly’s Miracle Weight Loss Pill May Not Be Miraculous Enough

Lilly’s second-quarter results reported Thursday were still more than fine: $15.5 billion in revenue beat Wall Street estimates.

2 min read
Photo via Abaca Press/Blondet Eliot/Abaca/Sipa USA/Newscom

Healthcare

Novo Nordisk Backs Away From Hims & Hers Partnership

Novo and Hims’ April team-up turned the two firms from competitors into collaborators at just the right moment.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.